New Stock News | Acrobiosystems (301080.SZ) Files Again with the Hong Kong Stock Exchange
According to a disclosure by the Hong Kong Stock Exchange on September 30, Beijing Acrobiosystems Biotechnology Co., Ltd. (referred to as: Acrobiosystems, 301080.SZ) has once again submitted a listing application to the Main Board of the Hong Kong Stock Exchange, with China Merchants Securities International acting as its sole sponsor.
According to a disclosure by the Hong Kong Stock Exchange on September 30, Beijing Acrobiosystems Biotechnology Co., Ltd. (referred to as Acrobiosystems, 301080.SZ) has once again submitted an application for listing on the Main Board of the Hong Kong Stock Exchange, with CMSC International acting as its sole sponsor. According to the prospectus, the company is primarily engaged in the research and development, production, and sales of recombinant proteins, antibodies, and analytical detection kits. According to Frost & Sullivan, based on 2025 revenue, the company ranks first among all Chinese suppliers in the global recombinant protein market and third among all suppliers, with a global market share of 2.7%, while the combined market share of the top two market participants is 33.0%.
Related Articles
Shenzhen Lifotronic Technology Co., Ltd. (688389.SH): H100Plus Hemoglobin Testing System Receives U.S. FDA 510(k) Clearance
LIANLIAN (02598) repurchased 90,500 shares for approximately HK$299,400 on October 8.
CHINANEWENERGY (01156): Zhang Junting has been appointed as an independent non-executive director.
Shenzhen Lifotronic Technology Co., Ltd. (688389.SH): H100Plus Hemoglobin Testing System Receives U.S. FDA 510(k) Clearance
LIANLIAN (02598) repurchased 90,500 shares for approximately HK$299,400 on October 8.
CHINANEWENERGY (01156): Zhang Junting has been appointed as an independent non-executive director.
